NCT02438098 - Rivaroxaban in Bariatric Surgery | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions

Prophylaxis of Venous Thromboembolism

Interventions

DRUG

Rivaroxaban 10 mg

Patients receive the day before the surgical intervention the first dose of Rivaroxaban (10 mg) p.o. The second tablet Rivaroxaban is administered on the third postoperative day.

Trial Locations (1)

3010

Department of Visceral Surgery and Medicine, University Hospital Bern, Bern